CLINICAL_TRIALS
trial_result
· 2025-12-18
Clinical Trial Update: Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK [NA]
Summary
Completed trial comparing 1-hour versus 2-hour illumination in indoor daylight photodynamic therapy for scalp actinic keratosis to evaluate whether shorter expo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: San Salvatore Hospital of L'Aquila | Conditions: Actinic Keratosis (AK) | NA | Status: COMPLETED